Comparison of the cost-effectiveness of a highand a low-intensity smoking cessation intervention in sweden: A randomized trial

Nicotine and Tobacco Research

Volumn 15, Issue 9, 2013, Pages 1519-1527

  Nohlert, Eva ^a   Helgason, Ásgeir R ^b,c   Tillgren, Per ^d   Tegelberg, Ake ^a,e   Johansson, Pia ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c REYKJAVIK UNIVERSITY   (Iceland)

^d MÄLARDALEN UNIVERSITY   (Sweden)

^e MALMÖ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; ECONOMIC EVALUATION; FEMALE; FOLLOW UP; HEALTH CARE COST; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PATIENT COUNSELING; PREVALENCE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION PROGRAM; SWEDEN;

EID: 84879669633     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntt009     Document Type: Article

References (39)

1. Andersson, F., & Kartman, B. (1995). The cost of angina pectoris in Sweden. Pharmacoeconomics, 8, 233-244. doi:10.2165/00019053-199508030-00006
2. Boldemann, C., Gilljam, H., Lund, K. E., & Helgason, A. R. (2006). Smoking cessation in general practice: The effects of a quitline. Nicotine Tobacco & Research, 8, 785-790. doi:10.1080/14622200601004059
3. Bolin, K. (2012). Economic evaluation of smoking-cessation therapies: A critical and systematic review of simulation models. Pharmacoeconomics, 30, 551-564. doi:10.2165/11590120-000000000-00000
4. Bolin, K., Mork, A. C., Willers, S., & Lindgren, B. (2008). Varenicline as compared to bupropion in smoking-cessation therapy--cost-utility results for Sweden 2003. Respiratory Medicine, 102, 699-710. doi:10.1016/ j.rmed.2007.12.018
5. Carr, A. B., & Ebbert, J. (2012). Interventions for tobacco cessation in the dental setting. Cochrane Database of Systematic Reviews, (6), CD005084. doi:10.1002/14651858. CD005084.pub3
6. Claesson, L., Gosman-Hedstrom, G., Johannesson, M., Fagerberg, B., & Blomstrand, C. (2000). Resource utilization and costs of stroke unit care integrated in a care continuum: A 1-year controlled, prospective, randomized study in elderly patients: The Goteborg 70+ Stroke Study. Stroke, 31, 2569-2577. doi:10.1161/01.STR.31.11.2569
7. Costa, M. L., Cohen, J. E., Chaiton, M. O., Ip, D., McDonald, P., & Ferrence, R. (2010). "Hardcore" definitions and their application to a population-based sample of smokers. Nicotine & Tobacco Research, 12, 860-864. doi:10.1093/ ntr/ntq103
8. Cromwell, J., Bartosch, W. J., Fiore, M. C., Hasselblad, V., & Baker, T. (1997). Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research. JAMA, 278, 1759-1766. doi:10.1001/jama.278.21.1759
9. Drummond, M., Sculpher, M., Torrance, G., O'Brien, J., & Stoddart, G. (2005). Methods for the economic evaluation of health care programmes (3rd ed.). Oxford: OUP.
10. Feenstra, T. L., Hamberg-van Reenen, H. H., Hoogenveen, R. T., & Rutten-van Molken, M. P. (2005). Cost-effectiveness of face-to-face smoking cessation interventions: A dynamic modeling study. Value in Health, 8, 178-190. doi:10.1111/ j.1524-4733.2005.04008.x
11. FHI. (2009). Tobak och avvänjning [Tobacco and weaning] (R 2009:17). östersund, Sweden: Statens folkhälsoinstitut (FHI) [Swedish National Institute of Public Health].
12. Fiore, M. C., Jaén, C. R., Baker, T. B., Bailey, W. C., Benowitz, N. L., Curry, S. J., . . . Wewers, M. E. (2008). Treating tobacco use and dependence: 2008 update. Clinical practice guideline. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service.
13. Ford, E. S., Kelly, A. E., Teutsch, S. M., Thacker, S. B., & Garbe, P. L. (1999). Radon and lung cancer: A cost-effectiveness analysis. American Journal of Public Health, 89, 351-357. doi:10.2105/AJPH.89.3.351
14. Glader, E. L., Stegmayr, B., Johansson, L., Hulter-Asberg, K., Staaf, A., & Wester, P. O. (2001). Slaganfall - och sedan? Omfattande hjälpbehov tva ar efter slaganfallet visar stor nationell studie [Stroke - and then? Considerable need of assistance two year after stroke according to a large nationwide study]. Lakartidningen, 98, 4462-4467.
15. Jansson, S. A., Andersson, F., Borg, S., Ericsson, A., Jonsson, E., & Lundback, B. (2002). Costs of COPD in Sweden according to disease severity. Chest, 122, 1994-2002. doi:10.1378/chest.122.6.1994
16. Javitz, H. S., Swan, G. E., Zbikowski, S. M., Curry, S. J., McAfee, T. A., Decker, D. L., . . . Jack, L. M. (2004). Cost-effectiveness of different combinations of bupropion SR dose and behavioral treatment for smoking cessation: A societal perspective. American Journal of Managed Care, 10, 217-226.
17. Johannesson, M., Hedbrant, J., & Jonsson, B. (1991). A computer simulation model for cost-effectiveness analysis of cardiovascular disease prevention. Medical Informatics (London), 16, 355-362.
18. Johansson, P. (2004). A model for economic evaluations of smoking cessation interventions - technical report. Stockholm, Sweden: Stockholm Centre for Public Health, Stockholm County Council.
19. Johansson, P. M., Tillgren, P. E., Guldbrandsson, K. A., & Lindholm, L. A. (2005). A model for cost-effectiveness analyses of smoking cessation interventions applied to a Quit-and-Win contest for mothers of small children. Scandinavian Journal of Public Health, 33, 343-352. doi:10.1080/14034940510005789
20. Kahende, J. W., Loomis, B. R., Adhikari, B., & Marshall, L. (2009). A review of economic evaluations of tobacco control programs. International Journal of Environmental Research and Public Health, 6, 51-68. doi:10.3390/ijerph6010051
21. Kannel, W. B., Wolf, P. A., & Garrison, R. J. (1987). The Framingham study: An epidemiological investigation of cardiovascular disease. Section 37: The probability of developing certain cardiovascular diseases in eight years at specified values of some characteristics (NIH Publication No. 87 2284). Alexandria, VA: National Technical Information Service.
22. Kannel, W. B., Wolf, P. A., Garrison, R. J., Cupples, L. A., D'Agostino, R. B., Kiely, D., & National Heart, Lung, and Blood Institute. (1988). The Framingham study: An epidemiological investigation of cardiovascular disease: Section 35: Survival following initial cardiovascular events: 30-year follow-up. Alexandria, VA: National Technical Information Service.
23. Lancaster, T., & Stead, L. F. (2005a). Individual behavioural counselling for smoking cessation. Cochrane Database of Systematic Reviews, (2), CD001292.
24. Lancaster, T., & Stead, L. F. (2005b). Self-help interventions for smoking cessation. Cochrane Database of Systematic Reviews, (3), CD001118. doi:10.1002/14651858.CD001118.pub2
25. LFN. (2003). General guidelines for economic evaluations from the Pharmaceutical Benefits Board (LFNAR 2003:2). Stockholm, Sweden: Läkemedelsförmansnämnden (LFN) [Swedish Pharmaceutical Benefits Board].
26. Nohlert, E., Tegelberg, A., Tillgren, P., Johansson, P., Rosenblad, A., & Helgason, A. R. (2009). Comparison of a high and a low intensity smoking cessation intervention in a dentistry setting in Sweden: A randomized trial. BMC Public Health, 9, 121. doi:10.1186/1471-2458-9-121
27. Peto, R., Darby, S., Deo, H., Silcocks, P., Whitley, E., & Doll, R. (2000). Smoking, smoking cessation, and lung cancer in the UK since 1950: Combination of national statistics with two case-control studies. British Medical Journal, 321, 323- 329. doi:10.1136/bmj.321.7257.323
28. Rasmussen, S. R., Prescott, E., Sorensen, T. I., & Sogaard, J. (2004). The total lifetime costs of smoking. European Journal of Public Health, 14, 95-100. doi:10.1093/eurpub/14.1.95
29. Ryden-Bergsten, T., & Andersson, F. (1999). The health care costs of heart failure in Sweden. Journal of Internal Medicine, 246, 275-284. doi:10.1046/j.1365-2796.1999.00520.x
30. Socialstyrelsen. (2004). Socialstyrelsens riktlinjer för hjärtsjukvard 2004 (Guidelines for cardiac care from The National Swedish Board of Health and Welfare 2004) [in Swedish]. Stockholm, Sweden: Socialstyrelsen [The National Swedish Board of Health and Welfare].
31. Statistics Sweden. (2001). Statistisk arsbok för Sverige 2000 [Statistical yearbook of salaries and wages 2000] (Vol. 87). örebro, Sweden: Statistiska Centralbyrån (SCB) [Statistics Sweden].
32. Stead, L. F., Bergson, G., & Lancaster, T. (2008). Physician advice for smoking cessation. Cochrane Database of Systematic Reviews, (2), CD000165.
33. Stead, L. F., Perera, R., & Lancaster, T. (2006). Telephone counselling for smoking cessation. Cochrane Database of Systematic Reviews, (3), CD002850.
34. Stenbeck, M., Rosen, M., & Holm, L. E. (1995). Cancer survival in Sweden during three decades, 1961-1991. Acta Oncologica, 34, 881-891. doi:10.3109/02841869509127200
35. Surgeon General. (1990). The health benefits of smoking cessation: A report of the Surgeon General. Rockville, MD: U.S. Department of Health and Human Services.
36. Thavorn, K., & Chaiyakunapruk, N. (2008). A cost-effectiveness analysis of a community pharmacist-based smoking cessation programme in Thailand. Tobacco Control, 17, 177-182. doi:10.1136/tc.2007.022368
37. von Koch, L., de Pedro-Cuesta, J., Kostulas, V., Almazan, J., & Widen Holmqvist, L. (2001). Randomized controlled trial of rehabilitation at home after stroke: one-year follow-up of patient outcome, resource use and cost. Cerebrovascular Diseases, 12, 131-138. doi:10.1159/000047692
38. Warner, K. E. (1997). Cost effectiveness of smoking-cessation therapies. Interpretation of the evidence-and implications for coverage. Pharmacoeconomics, 11, 538-549. doi:10.2165/00019053-199711060-00003
39. Zethraeus, N., Molin, T., Henriksson, P., & Jonsson, B. (1999). Costs of coronary heart disease and stroke: The case of Sweden. Journal of Internal Medicine, 246, 151-159. doi:10.1046/j.1365-2796.1999.00546.x